Search hospitals > Oregon > Portland

Providence Portland Medical Center

Claim this profile
Portland, Oregon 97213
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Melanoma
578 reported clinical trials
37 medical researchers
Photo of Providence Portland Medical Center in PortlandPhoto of Providence Portland Medical Center in PortlandPhoto of Providence Portland Medical Center in Portland

Summary

Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Melanoma and other specialties. Providence Portland Medical Center is involved with conducting 578 clinical trials across 561 conditions. There are 37 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.

Area of expertise

1Cancer
Global Leader
Providence Portland Medical Center has run 178 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Providence Portland Medical Center has run 88 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Providence Portland Medical Center

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Squamous Cell Carcinoma
Cancer
Esophageal Cancer
Gastric Cancer
Ovarian Tumors
Multiple Myeloma
Tumors
Image of trial facility.

Tucatinib Combination

for Breast Cancer

Patients with advanced HER2+ breast cancer on maintenance trastuzumab/pertuzumab or T-DM1 with 1st or 2nd intracranial disease event (brain metastases) and stable extracranial disease will be enrolled. They will receive local therapy with stereotactic radiosurgery ± surgical resection if indicated followed by enrollment. Patients will continue standard of care trastuzumab/pertuzumab or T-DM1 with the addition of tucatinib. Hormone receptor positive patients requiring endocrine therapy should continue. Study treatment will continue until disease progression or intolerable side effects. Patients on trial with extracranial disease progression with stable intracranial disease should continue tucatinib into next line of therapy.
Recruiting3 awards Phase 29 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

ARV-471

for Breast Cancer

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer.
Recruiting2 awards Phase 35 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Providence Portland Medical Center?
Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Melanoma and other specialties. Providence Portland Medical Center is involved with conducting 578 clinical trials across 561 conditions. There are 37 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.
Where is Providence Portland Medical Center located?
**Providence Portland Medical Center** - **Address:** 4805 NE Glisan St, Portland, OR 97213 - **Accessibility:** Easily accessible via public transit, including bus and light rail options. - **Specialties:** Renowned for excellence in cancer, heart, orthopedics, women's health, rehabilitation services, and behavioral health.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Providence Portland Medical Center: - Contact financial counselors at **855-229-6466**, available Monday – Friday, 7 a.m. to 5:30 p.m. PT. - For billing inquiries related to Providence Hospitals & Clinics, call **866-747-2455** (toll-free) or **503-574-5791** (local - Portland metro area). - For billing inquiries related to Providence Health Plan, call **800-878-4445** (toll-free) or **503-574-5791** (local - Portland metro area).
What insurance does Providence Portland Medical Center accept?
Providence Portland Medical Center accepts a wide range of health plans, including Aetna, Blue Cross Blue Shield, Cigna, Coventry, First Health, Humana, MultiPlan, Private Healthcare Systems (PHCS), TRICARE for Life, United Healthcare, and more. The hospital also accepts various Medicare and Medicaid plans, alongside commercial/indemnity insurance plans. For the most accurate information regarding coverage, please check directly with your insurance provider and the hospital.
What awards or recognition has Providence Portland Medical Center received?
Providence Portland Medical Center, located in Portland, Oregon, has been awarded a Health Care Innovation Award of $17,337,093 for transforming the delivery system of Oregon's largest Medicaid Coordinated Care Organization (CCO). This initiative focuses on enhancing care coordination, quality, and outcomes for high-cost, high-acuity Medicaid patients while aiming to reduce overall health care costs. The hospital is renowned for its excellence in patient care and research, particularly in cancer, heart, orthopedics, women's health, rehabilitation services, and behavioral health, and holds the prestigious Magnet® designation for nursing excellence.